Abu Dhabi brings global leaders from 7-9 April at the Future Health Summit.

Senior Regional Manager Bashir Mohamed joins this event at ADNEC to explore genomics & AI integration.

Attending #ADGHW? Connect with Bashir to discuss the future of regional healthcare.

#UAEHealth #MedTech

Biomerica stock rises after UAE health ministry approves kidney test Investing.com -- Biomerica Inc (NASDAQ:BMRA) stock rose 7% in premarket trading Wednesday after the company announced that the United Arab Emirates Ministry of Health and Prevention has approved its Fortel Kidney Test for home use. The diagnostic test detects low levels of albumin in urine, an early marker of kidney disease, in just 10 minutes. It is designed particularly for individuals with diabetes and hypertension, who face higher risks of developing chronic kidney disease. This regulatory approval represents a significant market opportunity for Biomerica in the UAE, where approximately one in four nationals have diabetes and about 31% of the population suffers from hypertension, according to a meta-analysis cited by the company. "The Fortel Kidney Test addresses a gap in preventative healthcare by allowing patients and physicians to detect kidney disease before symptoms appear," said Zack Irani, CEO of Biomerica. "With the high prevalence of diabetes and hypertension in the UAE, this approval supports our mission to bring life-saving diagnostic tools to communities where they are most needed." The company plans to make the test available in pharmacies, clinics, and hospitals throughout the UAE through partnerships with distributors and healthcare providers. This approval strengthens Biomerica’s presence in the Middle East, following the regional success of its EZ Detect Colon Disease Test. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C. 3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads. ProPicks AI evaluates BMRA alongside thousands of other companies every month using 100+ financial metrics. Using powerful AI to generate exciting stock ideas, it looks beyond popularity to assess fundamentals, momentum, and valuation. The AI has no bias—it simply identifies which stocks offer the best risk-reward based on current data with notable past winners that include Super Micro Computer (+185%) and AppLovin (+157%). Want to know if BMRA is currently featured in any ProPicks AI strategies, or if there are better opportunities in the same space?

Click Subscribe #Biomerica #StockMarket #UAEHealth #KidneyHealth #Investing

One login, one profile, all emirates. 🚀 The UAE’s Unified Health Licensing Platform is slated for Q2 2026—AI guidance, fewer duplicate steps
#UAEHealth #MoHAP #DHA #DOH #SHA #HealthcareLicensing #DigitalHealth #ZeroBureaucracy #NursingManthra
zurl.co/vQYBg